Proteome Sciences is a global leader in applied proteomics applying high sensitivity proprietary technologies to detect differentially expressed proteins in diseases.
Proteome Sciences, is involved in applied proteomics, uses high sensitivity proprietary technologies to detect biomarkers (differentially expressed proteins in diseases). The biomarkers discovered in body fluids or tissues are validated, developed and commercialised as diagnostic, prognostic or therapeutic products through strategic alliances and out-licensing. Since its inception in 1994, Proteome Sciences has discovered a large number of novel protein biomarkers in key human diseases and has established a broad portfolio of products/licensing from Intellectual Property (IP) related to differential protein expression.
R&D
To view this information, you must subscribe to PL Intelligence.
Partnerships
To view this information, you must subscribe to PL Intelligence.
Deals
To view this information, you must subscribe to PL Intelligence.
Senior management
To view this information, you must subscribe to PL Intelligence.
Board of directors
To view this information, you must subscribe to PL Intelligence.
Contact details
To view this information, you must subscribe to PL Intelligence.
Head office
Proteome Sciences
Coveham House
Downside Bridge Road
Cobham
Surrey
KT11 3EP United Kingdom
All rights reserved. Terms and Conditions | Contact us
